Factors Associated With Drug Consumption Without Scientific Evidence in Patients With Mild COVID-19 in Peru
Author(s)
David R. Soriano‐Moreno
Daniel Fernandez‐Guzman
Lucero Sangster-Carrasco
Carlos Quispe‐Vicuña
Pamela Grados‐Espinoza
Fabricio Ccami‐Bernal
Noelia Morocho-Alburqueque
Naomi Coba-Villan
Randy Velasquez-Fernandez
Wendy Nieto-Gutiérrez
Date Issued
20 de julio de 2022
Type
Article
Volume
18
Issue
8
Start Page
e1189
End Page
e1195
Abstract
OBJECTIVE: This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. METHODS: An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. RESULTS: Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65). CONCLUSIONS: Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.
Keywords